The Increasing Importance of GLP-1–Based Therapies for Personalized Obesity Management
Co-Chairs, Domenica M. Rubino, MD, and Donna H. Ryan, MD, FTOS, discuss the role of weight-loss medications for long-term obesity management in this CME activity titled “Gut Feeling: The Increasing Importance of GLP-1–Based Therapies for Personalized Obesity Management.” For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/WBN865. CME credit will be available until December 8, 2022.
